Almost 40% of the county’s 2024 homicides were from instances of IPV.
Spotlight on VPM Original Content
Virginia News
NPR News
Virginia News
-
Maggie Clemmons is on leave amid review of workplace culture and harassment allegations.
-
Retired Army Maj. Gen. Cedric T. Wins' ouster follows pushback on DEI by some conservative alumni.
-
Who’s Dillon, and why does the commonwealth follow his rule?
-
The board initially sought a $43.7M hike over the previous year.
-
Virginia is the only state that requires lawmakers to approve individual payments.
-
The plaque gives context to the sale of enslaved people in the Charlottesville area.
NPR News
-
Consumer prices in April were up 2.3% from a year ago, the smallest annual increase in more than four years. Grocery prices fell 0.4%, thanks to a large drop in the price of eggs.
-
Amid uncertainty around President Trump's tariffs, some Champagne-makers say they're losing trust in the U.S. market.
-
Importers are ready to get back to business after the U.S. cut tariffs on China, but uncertainty looms. And, media mogul Diddy's first day of trial held a slew of accusations.
-
Jay Foreman, CEO of Basic Fun!, says the Trump administration's shifting tariff policy has created chaos for businesses — and could still disrupt the holiday season.
-
Businesses are rushing to import Chinese goods after the U.S. struck a temporary deal. This "stop-go" nature of trade could still mean higher prices and doesn't ease uncertainty, an economist warns.
Arts & Culture
- Tara Roberts helps scuba divers uncover slave shipwrecks
- New Burying Ground honors enslaved labor at University of Richmond
- Museums, libraries and cultural groups grapple with federal humanities cuts
- ‘Idleness and boredom’: Virginia juvenile justice system strained by staffing shortages
Listen to VPM
- VPM Daily Newscast: Richmond City Council finalizes $3 billion FY26 budget
- Guest conductor Michael Repper leads the Richmond Symphony in Berlioz's Symphonie Fantastique
- VPM Daily Newscast: ‘Catalyst’ UVA Manning Institute for Biotechnology
- Interview: Keep finds the new normal